Potential of Pan-Tuberculosis Treatment to Drive Emergence of Novel Resistance
Emerging Infectious Diseases · 2024
DOI: 10.3201/eid3008.240541 ↗Kurz gefasst
Fachartikel in der Zeitschrift Emerging Infectious Diseases, 2024. Verfasst von C Finn McQuaid und 5 weiteren Autor:innen. Hauptthemen laut MEDLINE: Antitubercular Agents, Mycobacterium tuberculosis, Microbial Sensitivity Tests. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Wellcome Trust, NIAID NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Förderung
- Wellcome Trust
- NIAID NIH HHS
Zitieren
APA
McQuaid, C. F., Ryckman, T. S., Menzies, N. A., White, R. G., Cohen, T., & Kendall, E. A. (2024). Potential of Pan-Tuberculosis Treatment to Drive Emergence of Novel Resistance. Emerging Infectious Diseases. https://doi.org/10.3201/eid3008.240541
Vancouver
McQuaid CF, Ryckman TS, Menzies NA, White RG, Cohen T, Kendall EA. Potential of Pan-Tuberculosis Treatment to Drive Emergence of Novel Resistance. Emerging Infectious Diseases. 2024. doi:10.3201/eid3008.240541
BibTeX
@article{McQuaid2024,
author = {McQuaid, C Finn and Ryckman, Theresa S and Menzies, Nicolas A and White, Richard G and Cohen, Ted and Kendall, Emily A},
title = {Potential of Pan-Tuberculosis Treatment to Drive Emergence of Novel Resistance},
journal = {Emerging Infectious Diseases},
year = {2024},
doi = {10.3201/eid3008.240541}
}
EUVIMED